antitrust risk Flash News List | Blockchain.News
Flash News List

List of Flash News about antitrust risk

Time Details
2025-12-10
17:36
WBD Stock Jumps 4.4% to $29.50 as PSKY Eyes Bid Above $30; NFLX $27.75 Offer Deemed Superior but Faces Antitrust Risk

According to Gary Black, WBD rose 4.4% to $29.50 and is likely to move higher as PSKY raises its bid above the prior $30 per share cash offer, source: Gary Black on X, Dec 10, 2025. He reports NFLX submitted a $27.75 per share proposal composed of $23.25 cash and $4.50 stock, deemed superior by WBD’s Board because it excludes the global network business slated for a spin-off that NFLX values at $3 per share, source: Gary Black on X, Dec 10, 2025. He adds that PSKY’s $30 per share cash bid covers the entire company including the global network business, source: Gary Black on X, Dec 10, 2025. He also notes the NFLX route faces regulatory headwinds given approximately 36% industry concentration for a combined NFLX/Paramount streaming business, source: Gary Black on X, Dec 10, 2025. No direct cryptocurrency market impact was cited, source: Gary Black on X, Dec 10, 2025.

Source
2025-12-05
14:50
Trump Administration’s ‘Heavy Skepticism’ Over Netflix (NFLX) $72B Bid for Warner Bros. Discovery (WBD) Film and Streaming Assets Signals Antitrust Risk for Traders

According to @StockMKTNewz, citing CNBC, the U.S. Trump administration reportedly views Netflix’s proposed $72 billion acquisition of Warner Bros. Discovery’s film and streaming assets with heavy skepticism, highlighting elevated regulatory and antitrust risk around the transaction (CNBC via @StockMKTNewz). For traders, the CNBC-reported stance introduces headline risk around deal odds and timing for NFLX and WBD, with the report explicitly characterizing the administration’s view as heavy skepticism and providing the $72 billion headline valuation (CNBC via @StockMKTNewz).

Source
2025-11-28
02:19
Mark Cuban Says Healthcare Markets Lack Efficiency: Scale-Driven Regulatory Capture and Trading Implications for Healthcare Stocks

According to @mcuban, scale in healthcare enables regulatory capture as large firms can buy enough companies and generate sufficient profits to influence the rules. Source: @mcuban on X, Nov 28, 2025. He adds that markets need efficiency and asserts healthcare markets have zero efficiency. Source: @mcuban on X, Nov 28, 2025. For traders, his comments flag headline and policy-risk sensitivity for large, consolidation-driven healthcare equities (insurers, PBMs, hospital roll-ups), where perceived regulatory capture could act as a negative sentiment catalyst in valuation screens and positioning. Source: @mcuban on X, Nov 28, 2025. Active strategies may focus on relative strength between mega-cap acquirers and smaller providers during antitrust, pricing, or M&A newsflow that aligns with this critique. Source: @mcuban on X, Nov 28, 2025.

Source
2025-11-28
02:01
Mark Cuban Calls to Break Up Dominant U.S. Healthcare Companies: Market Structure Warning for Investors

According to Mark Cuban, U.S. healthcare is available to everyone but is a mess because it is dominated by a few companies, underscoring a market structure problem, source: Mark Cuban on X, Nov 28, 2025. He urges breaking up these dominant firms so doctors are paid more and more patients can be cared for, framing the issue squarely as market structure, source: Mark Cuban on X, Nov 28, 2025. The post does not reference crypto assets or tokens, source: Mark Cuban on X, Nov 28, 2025.

Source